Johnson and Johnson: Cautiously Optimistic at $68/Share
by | Posted 9.22.2012 | Post Comment (No Comments)

Johnson and Johnson is an extremely diverse pharmaceutical, medical device, and consumer products company that is approaching its 50th consecutive annual dividend increases.

-Seven Year Revenue Growth Rate: 4.6%
-Seven Year EPS Growth Rate: 2.9%
-Seven Year Dividend Growth Rate: 10.7%
-Current Dividend Yield: 3.56%
-Balance Sheet Strength: Very Strong

Read the rest of this post @ DividendMonk